Global Innovative Platforms Inc
Global Innovative Platforms, Inc. (OTC Pink: GIPL) is a development-stage veterinary diagnostics company focused on developing non-invasive breath analysis technology for the early detection of heartworm disease in dogs. The company is developing a diagnostic platform using VOCAM Plus breath analysis hardware together with FROG signal processing technology and Ellvin AI software, all licensed from Defiant Technologies, Inc. Heartworm disease is a serious and potentially life-threatening condition caused by parasitic worms that infect the heart, lungs, and pulmonary arteries of dogs, and current diagnostic methods require blood testing that can miss early-stage infections before sufficient antigen levels are present.<br><br>A breath-based diagnostic approach would offer the potential for a non-invasive, stress-free alternative to venipuncture blood testing for veterinary practices and pet owners seeking to monitor their dogs for heartworm infection. Global Innovative Platforms began algorithm development for its AI-driven heartworm detection system in March 2025, with initial feasibility studies conducted on a small sample set and validation work planned to continue into 2026. The company has not yet generated revenue from its diagnostic platform and reported a retained deficit of approximately $1.25 million through its fiscal year ended September 30, 2025, with auditors including a going concern qualification reflecting the early-stage nature of its product development activities.<br><br>Global Innovative Platforms, Inc. was incorporated in 2020 and is headquartered in Orlando, Florida. The company's common stock is quoted on the OTC Pink Current Information tier under the ticker symbol GIPL and files periodic reports with the Securities and Exchange Commission under its Regulation A+ offering. The veterinary diagnostics market has experienced significant growth alongside rising pet ownership and increased pet healthcare spending, with pet owners increasingly seeking advanced diagnostic tools that provide earlier, more accurate disease detection to support proactive health management for their animals. Global Innovative Platforms is developing its AI-driven breath analysis platform to serve this growing demand for innovative, non-invasive veterinary diagnostics.